Given that IR plays a key role in the pathogenesis of NAFLD, many studies have evaluated the use of insulin sensitizers for the improvement of peripheral insulin sensitivity as a possible treatment for this disease. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.